Trading Options with an Edge
Select Page

DNLI

Search by
TICKER SYMBOL

Denali Therapeutics Inc

Sector: Manufacturing
Industry: Biological Product (except Diagnostic) Manufacturing

52.83

-0.2

(-0.377%)

Volume:

1,854,707

52 week range:

33.68 - 93.94

Market Cap:

6.426B

Company Description:

Denali Therapeutics is a biopharmaceutical company developing a broad portfolio of product candidates engineered to cross the blood-brain barrier (BBB) for neurodegenerative diseases. Denali pursues new treatments by rigorously assessing genetically validated targets, engineering delivery across the BBB and guiding development through biomarkers that demonstrate target and pathway engagement. Denali is based in South San Francisco.